Imedex® is an industry leader in providing certified, independent continuing medical education to health care professionals.

August 4-5, 2017

Philadelphia, PA

Continuing Education

Imedex is accredited by the Accreditation Council for Continuing Medical Education (ACCME®) to provide continuing medical education for physicians.

Imedex®, LLC designates this live activity for a maximum of 9.0 AMA PRA Category 1 Credits™. Physicians should claim only credit commensurate with the extent of their participation in the activity.

Maintenance of Certification​
Successful completion of this CME activity enables a participant to earn up to 9.0 MOC points towards the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is Imedex’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC Points.

Who Should Attend
This live educational activity is designed to meet the educational needs of hematologists, medical oncologists and other healthcare professionals (physicians, physicians-in-training, oncology nurses, pharmacists, physician assistants, nurse practitioners, etc.) who are involved and/or interested in the treatment of patients with MPN and MDS.

Objectives
After successful completion of this activity, participants should be able to:

  • Relate the role of molecular, genetic, and immunologic factors to the pathogenesis of MPN and MDS
  • Utilize updated diagnostic and treatment guidelines for the management of MPN and MDS
  • Identify the mechanistic activity, efficacy, and safety profiles of current and emerging therapies for the treatment of MPN and MDS
  • Describe new diagnostic and therapeutic approaches that can be integrated into the management of MPN and MDS based on recent advances in the field.